Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity

Anastasia Anthi, Eleni Stagaki, Loukianos Rallidis, Dimitrios Konstantonis, Maria-Eleftheria Evangelopoulos, Konstantinos Voumvourakis, Apostolos Armaganidis, Stylianos E. Orfanos
ERJ Open Research 2020 6: 00328-2019; DOI: 10.1183/23120541.00328-2019
Anastasia Anthi
1Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece
22nd Dept of Critical Care, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anastasia.anthi1@gmail.com
Eleni Stagaki
1Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loukianos Rallidis
1Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece
32nd Dept of Cardiology, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitrios Konstantonis
1Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece
22nd Dept of Critical Care, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria-Eleftheria Evangelopoulos
4Demyelinating Diseases Unit, Dept of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Voumvourakis
52nd Dept of Neurology, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apostolos Armaganidis
1Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece
22nd Dept of Critical Care, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Apostolos Armaganidis
Stylianos E. Orfanos
1Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece
22nd Dept of Critical Care, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 6 no. 1
DOI 
https://doi.org/10.1183/23120541.00328-2019

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received December 3, 2019
  • Accepted February 6, 2020
  • Published online March 16, 2020.

Copyright & Usage 
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Anastasia Anthi1,2⇑,
  2. Eleni Stagaki1,
  3. Loukianos Rallidis1,3,
  4. Dimitrios Konstantonis1,2,
  5. Maria-Eleftheria Evangelopoulos4,
  6. Konstantinos Voumvourakis5,
  7. Apostolos Armaganidis1,2 and
  8. Stylianos E. Orfanos1,2
  1. 1Pulmonary Hypertension Clinic, “Attikon” Hospital, Athens, Greece
  2. 22nd Dept of Critical Care, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  3. 32nd Dept of Cardiology, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  4. 4Demyelinating Diseases Unit, Dept of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece
  5. 52nd Dept of Neurology, National and Kapodistrian University of Athens, “Attikon” Hospital, Athens, Greece
  1. Anastasia Anthi, 2nd Department of Critical Care, Attikon University Hospital, 1, Rimini St, 12462, Haïdari Athens, Greece. E-mail: anastasia.anthi1{at}gmail.com
View Full Text

Article usage

Article usage: March 2020 to February 2023

AbstractFullPdf
Mar 2020117254
Apr 202047016
May 202023615
Jun 202021811
Jul 20201186
Aug 20201388
Sep 20200604
Oct 20201475
Nov 20201247
Dec 20201289
Jan 20213208
Feb 20210599
Mar 202114010
Apr 20210154
May 20210296
Jun 2021171
Jul 202101411
Aug 20211166
Sep 20210287
Oct 202112115
Nov 202104720
Dec 20210315
Jan 20220133
Feb 20220121
Mar 2022062
Apr 2022054
May 202201822
Jun 2022072
Jul 20221101
Aug 20223145
Sep 2022198
Oct 202221215
Nov 20220105
Dec 20220164
Jan 202311512
Feb 20230155

Altmetrics

PreviousNext
Back to top
Vol 6 Issue 1 Table of Contents
ERJ Open Research: 6 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
Anastasia Anthi, Eleni Stagaki, Loukianos Rallidis, Dimitrios Konstantonis, Maria-Eleftheria Evangelopoulos, Konstantinos Voumvourakis, Apostolos Armaganidis, Stylianos E. Orfanos
ERJ Open Research Jan 2020, 6 (1) 00328-2019; DOI: 10.1183/23120541.00328-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
Anastasia Anthi, Eleni Stagaki, Loukianos Rallidis, Dimitrios Konstantonis, Maria-Eleftheria Evangelopoulos, Konstantinos Voumvourakis, Apostolos Armaganidis, Stylianos E. Orfanos
ERJ Open Research Jan 2020, 6 (1) 00328-2019; DOI: 10.1183/23120541.00328-2019
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • rs2070600 SNP regulates AGER splicing and sputum sRAGE
  • Procoagulant microparticles and COVID-19
  • Cancer referral and interventional pulmonology during COVID-19
Show more Original research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society